Last updated on June 2020

A Study Evaluating Venetoclax in Combination With Azacitidine in Participants With Treatment-Na ve Higher-Risk Myelodysplastic Syndromes (MDS)


Brief description of study

This is a Phase 1b, open-label, non-randomized, multicenter, dose-finding study evaluating venetoclax in combination with azacitidine in participants with treatment-nave higher-risk MDS comprising a dose-escalation portion and a safety expansion portion.

Clinical Study Identifier: NCT02942290

Find a site near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.